Pantoprazole Macleods Pharma Uk

Pantoprazole, the active ingredient in Pantoprazole Macleods Pharma Uk, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Pantoprazole Macleods Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that lowers gastric acid secretion in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing acid exposure to the oesophagus. - Erosive oesophagitis: promotes healing of acid‑induced oesophageal lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid production caused by gastrin‑secreting tumours.

Pantoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain often resolving without treatment. - Diarrhoea: loose stools that usually improve with continued therapy. - Nausea: feeling of queasiness, typically mild. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, and breathing difficulty. - Clostridioides difficile infection: severe diarrhoea due to bacterial overgrowth. - Low magnesium levels: may cause muscle cramps, weakness, or cardiac arrhythmias.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium levels: prolonged treatment can lead to deficiency. - Review concomitant medications that require gastric acidity for absorption. - Use with caution in patients with hepatic disease. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy. - Atorvastatin: increased statin exposure, raising risk of myopathy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR for potential anticoagulation changes. - Methotrexate: possible increase in methotrexate serum levels.